PL2036575T3 - Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością - Google Patents

Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością

Info

Publication number
PL2036575T3
PL2036575T3 PL07425563T PL07425563T PL2036575T3 PL 2036575 T3 PL2036575 T3 PL 2036575T3 PL 07425563 T PL07425563 T PL 07425563T PL 07425563 T PL07425563 T PL 07425563T PL 2036575 T3 PL2036575 T3 PL 2036575T3
Authority
PL
Poland
Prior art keywords
obesity
pharmaceutical compositions
oral use
treating patients
patients affected
Prior art date
Application number
PL07425563T
Other languages
English (en)
Inventor
Guido Vandoni
Heny Cassia Zaniboni
Original Assignee
Mader S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mader S R L filed Critical Mader S R L
Publication of PL2036575T3 publication Critical patent/PL2036575T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07425563T 2007-09-12 2007-09-12 Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością PL2036575T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07425563A EP2036575B1 (en) 2007-09-12 2007-09-12 Pharmaceutical compositions for oral use for treating patients affected by obesity

Publications (1)

Publication Number Publication Date
PL2036575T3 true PL2036575T3 (pl) 2011-02-28

Family

ID=38983405

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07425563T PL2036575T3 (pl) 2007-09-12 2007-09-12 Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością

Country Status (10)

Country Link
US (1) US20100221326A1 (pl)
EP (1) EP2036575B1 (pl)
JP (1) JP2010539137A (pl)
AT (1) ATE477820T1 (pl)
AU (1) AU2008300030A1 (pl)
CA (1) CA2698882A1 (pl)
DE (1) DE602007008567D1 (pl)
ES (1) ES2350798T3 (pl)
PL (1) PL2036575T3 (pl)
WO (1) WO2009034171A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100958197B1 (ko) 2008-02-20 2010-05-14 (주)국전약품 올리스타트를 포함하는 약학적 조성물 및 이의 제조 방법
BRPI0901602B8 (pt) * 2009-04-03 2021-05-25 Ems S/A formulação farmacêuticas
CN108785272B (zh) * 2018-09-04 2019-04-09 中山万汉制药有限公司 一种奥利司他软胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE292975T1 (de) * 1997-02-05 2005-04-15 Hoffmann La Roche Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
AR025609A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
WO2003009840A1 (en) * 2001-07-24 2003-02-06 Lonza Ag Composition comprising at least one lipase inhibitor and carnitine
IL162323A0 (en) * 2001-12-04 2005-11-20 Biogal Pharmaceutical Co Preparation of orlistat and orlistat crystalline forms
BRPI0309406B1 (pt) * 2002-04-26 2017-04-11 Hoffmann La Roche composição farmacêutica, processo para preparar a referida composição, kit para tratamento de obesidade e uso da referida composição na fabricação de composições úteis para o tratamento e prevenção de obesidade
EP1591114A1 (en) * 2004-03-12 2005-11-02 Fournier Laboratories Ireland Limited Use of metformin and orlistat for the treatment or prevention of obesity

Also Published As

Publication number Publication date
EP2036575A1 (en) 2009-03-18
US20100221326A1 (en) 2010-09-02
ATE477820T1 (de) 2010-09-15
AU2008300030A1 (en) 2009-03-19
ES2350798T3 (es) 2011-01-27
JP2010539137A (ja) 2010-12-16
DE602007008567D1 (de) 2010-09-30
CA2698882A1 (en) 2009-03-19
WO2009034171A1 (en) 2009-03-19
EP2036575B1 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
HK1217339A1 (zh) 治療或預防大腸桿菌導致的經口感染的組合物和方法
EP1876990A4 (en) DENTAL TREATMENT THROUGH ALIGNMENT ELEMENTS
IL195571A0 (en) Compounds for the treatment of periodontal disease
HK1144390A1 (en) Compositions for the treatment of neoplastic diseases
ZA200902374B (en) Compositions useful for the treatment of diabetes
IL205671A0 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
EP2382176A4 (en) USE OF CURCUMIN ANALOGUES CONTAINING NITROGEN FOR THE TREATMENT OF ALZHEIMER'S DISEASE
TN2011000291A1 (en) Purine compounds
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
SI2024368T1 (sl) Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine
ZA201005116B (en) 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX2011011618A (es) Agentes terapeuticos 713.
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
HU0500145D0 (en) Composition for the treatment of oral diseases
PL2036575T3 (pl) Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością
DE602008002598D1 (en) Cyclohexylderivate
HK1147064A1 (en) Pharmaceutical compositions for treating anxiety
PT2344166E (pt) Composição farmacêutica para o tratamento da irritação gastrointestinal
EP2331099A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES MELLITUS
BRPI1008207A2 (pt) "composição farmacêutica para tratamento de efeitos colateriais por administração de spiegelmers."
HK1129112A1 (en) 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
IL200192A0 (en) Composition useful for the treatment of type 2 diabetes
IT1397219B1 (it) Composizione farmaceutica o dietetica per il trattamento dell'atopia